Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Monitoris AG

History from 27 Aug 2024

UID
CHE-337.159.926
Legal form
AG
Canton
ZH
Founded
27 Aug 2024
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 175k
125k250k375k500k19 Dec 2024 · CHF 125k15 Jul 2025 · CHF 138k10 Jun 2026 · CHF 175k20252026
  • shares

Record

  1. Company formed

    Founded 27 Aug 2024

    SHAB HR01-1006117775 ↗
  2. Capital reduction

    Payment not stated

    Nominal capital
    500’000 → 100’000
    Shares
    500’000 → 10’000’000
    New shares, % of post-step shares
    — (capital reduction)

    Aktienkapital neu: CHF 100'000.00 [bisher: CHF 500'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00 [bisher: CHF 250'000.00]. Aktien neu: 10'000'000 Namenaktien zu CHF 0.01 [bisher: 500'000 Namenaktien zu CHF 1.00]. Bei der Kapitalherabsetzung vom 29.10.2024 werden 400'000 Namenaktien zu CHF 1.00 vernichtet.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006173470 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 125’000
    Shares
    10’000’000 → 12’500’000
    New shares, % of post-step shares
    20.0% (2’500’000 new)

    Aktienkapital neu: CHF 125'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 125'000.00 [bisher: CHF 100'000.00]. Aktien neu: 12'500'000 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006209611 ↗
  4. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    125’000 → 137’500
    Shares
    12’500’000 → 13’750’000
    New shares, % of post-step shares
    9.1% (1’250’000 new)

    Aktienkapital neu: CHF 137'500.00 [bisher: CHF 125'000.00]. Liberierung Aktienkapital neu: CHF 137'500.00 [bisher: CHF 125'000.00]. Aktien neu: 13'750'000 Namenaktien zu CHF 0.01 [bisher: 12'500'000 Namenaktien zu CHF 0.01]. Qualifizierte Tatbestände neu: Bei der Kapitalerhöhung vom 27.06/10.07.2025 wird frei verwendbares Eigenkapital in der Höhe von CHF 12'500.00 umgewandelt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006384424 ↗
  5. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    137’500 → 175’000
    Shares
    13’750’000 → 17’500’000
    New shares, % of post-step shares
    21.4% (3’750’000 new)

    Aktienkapital neu: CHF 175'000.00 [bisher: CHF 137'500.00]. Liberierung Aktienkapital neu: CHF 175'000.00 [bisher: CHF 137'500.00]. Aktien neu: 17'500'000 Namenaktien zu CHF 0.01 [bisher: 13'750'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006672144 ↗

Published by 8 Oct 2026